Following combined treatment with PI3K/mTOR inhibitor and gamma ionizing radiation, the expression of FOXO1 and stem cell marker SOX2 is decreased in GBM stem cells with wild p53 phenotype [136]. This evidence concerns the gene FOXO1 and glioblastoma.